Assessment of the Skin-Concentration of Vildagliptin 50 mg Every 12 Hours for 10 Days in Healthy Subjects and Patients With Type 2 Diabetes

This study has been terminated.

( After analysis of the existing data, it was determined that additional skin biopsy samples would not be required to determine study outcome. )

Study NCT00633997 Information provided by Novartis

First Received: March 4, 2008 Last Updated: June 16, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	No date given
Primary Completion Date:	December 2008 (Final data collection date for primary outcome measure)